Annual Accounts Payable
$3.50 M
-$3.65 M-51.04%
December 31, 2024
Summary
- As of March 8, 2025, VNDA annual accounts payable is $3.50 million, with the most recent change of -$3.65 million (-51.04%) on December 31, 2024.
- During the last 3 years, VNDA annual accounts payable has risen by +$2.57 million (+278.16%).
- VNDA annual accounts payable is now -98.45% below its all-time high of $226.10 million, reached on December 1, 2003.
Performance
VNDA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.50 M
-$2.31 M-39.78%
December 31, 2024
Summary
- As of March 8, 2025, VNDA quarterly accounts payable is $3.50 million, with the most recent change of -$2.31 million (-39.78%) on December 31, 2024.
- Over the past year, VNDA quarterly accounts payable has dropped by -$844.00 thousand (-19.44%).
- VNDA quarterly accounts payable is now -78.69% below its all-time high of $16.41 million, reached on June 30, 2022.
Performance
VNDA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VNDA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.0% | -19.4% |
| 3 y3 years | +278.2% | -19.4% |
| 5 y5 years | - | -19.4% |
VNDA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -72.4% | +278.2% | -78.7% | +278.2% |
| 5 y | 5-year | -72.4% | +278.2% | -78.7% | +278.2% |
| alltime | all time | -98.5% | +1118.8% | -78.7% | +1310.5% |
Vanda Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $3.50 M(-51.0%) | $3.50 M(-39.8%) |
| Sep 2024 | - | $5.81 M(+156.4%) |
| Jun 2024 | - | $2.27 M(-47.8%) |
| Mar 2024 | - | $4.34 M(-39.2%) |
| Dec 2023 | $7.14 M(-43.7%) | $7.14 M(+104.8%) |
| Sep 2023 | - | $3.49 M(+60.7%) |
| Jun 2023 | - | $2.17 M(-42.9%) |
| Mar 2023 | - | $3.80 M(-70.1%) |
| Dec 2022 | $12.69 M(+1271.9%) | $12.69 M(-5.5%) |
| Sep 2022 | - | $13.43 M(-18.2%) |
| Jun 2022 | - | $16.41 M(+14.6%) |
| Mar 2022 | - | $14.33 M(+1448.9%) |
| Dec 2021 | $925.00 K(-11.8%) | $925.00 K(-28.8%) |
| Sep 2021 | - | $1.30 M(-38.6%) |
| Jun 2021 | - | $2.12 M(+101.8%) |
| Dec 2020 | $1.05 M(+58.7%) | $1.05 M(-35.7%) |
| Jun 2015 | - | $1.63 M(+9.5%) |
| Mar 2015 | - | $1.49 M(+172.4%) |
| Sep 2014 | - | $547.00 K(+120.6%) |
| Jun 2014 | - | $248.00 K(-74.0%) |
| Mar 2014 | - | $953.00 K(+44.2%) |
| Dec 2013 | $661.00 K(+130.3%) | $661.00 K(+79.1%) |
| Sep 2013 | - | $369.00 K(-68.4%) |
| Jun 2013 | - | $1.17 M(+4.9%) |
| Mar 2013 | - | $1.11 M(+287.8%) |
| Dec 2012 | $287.00 K | $287.00 K(-73.7%) |
| Sep 2012 | - | $1.09 M(-35.5%) |
| Jun 2012 | - | $1.69 M(+116.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $780.00 K(-21.7%) |
| Dec 2011 | $996.00 K(+53.7%) | $996.00 K(-25.3%) |
| Sep 2011 | - | $1.33 M(-0.3%) |
| Jun 2011 | - | $1.34 M(+60.3%) |
| Mar 2011 | - | $834.00 K(+28.7%) |
| Dec 2010 | $648.00 K(-73.3%) | $648.00 K(+119.3%) |
| Sep 2010 | - | $295.50 K(-71.0%) |
| Jun 2010 | - | $1.02 M(+17.5%) |
| Mar 2010 | - | $867.80 K(-64.2%) |
| Dec 2009 | $2.42 M(+373.1%) | $2.42 M(-61.8%) |
| Sep 2009 | - | $6.35 M(-8.3%) |
| Jun 2009 | - | $6.92 M(+388.7%) |
| Mar 2009 | - | $1.42 M(+176.2%) |
| Dec 2008 | $512.40 K(-82.9%) | $512.40 K(-43.0%) |
| Sep 2008 | - | $899.00 K(-84.6%) |
| Jun 2008 | - | $5.83 M(+219.1%) |
| Mar 2008 | - | $1.83 M(-38.9%) |
| Dec 2007 | $2.99 M(+7.4%) | $2.99 M(-13.3%) |
| Sep 2007 | - | $3.45 M(+32.5%) |
| Jun 2007 | - | $2.60 M(+29.4%) |
| Mar 2007 | - | $2.01 M(-27.8%) |
| Dec 2006 | $2.78 M(+23.4%) | $2.78 M(+31.8%) |
| Sep 2006 | - | $2.11 M(-58.3%) |
| Jun 2006 | - | $5.06 M(+49.9%) |
| Mar 2006 | - | $3.38 M(+49.8%) |
| Dec 2005 | $2.25 M(+213.8%) | $2.25 M |
| Dec 2004 | $718.60 K(-99.7%) | - |
| Dec 2003 | $226.10 M(+11.5%) | - |
| Dec 2002 | $202.76 M | - |
FAQ
- What is Vanda Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual accounts payable year-on-year change?
- What is Vanda Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly accounts payable year-on-year change?
What is Vanda Pharmaceuticals annual accounts payable?
The current annual accounts payable of VNDA is $3.50 M
What is the all time high annual accounts payable for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual accounts payable is $226.10 M
What is Vanda Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, VNDA annual accounts payable has changed by -$3.65 M (-51.04%)
What is Vanda Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of VNDA is $3.50 M
What is the all time high quarterly accounts payable for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly accounts payable is $16.41 M
What is Vanda Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, VNDA quarterly accounts payable has changed by -$844.00 K (-19.44%)